Coronary artery inflammation is a critical process in the pathogenesis of myocardial infarction (MI). The chemokine CCL5/RANTES (regulated upon activation, normal T cells expressed and secreted) is expressed in advanced atherosclerotic lesions. Functional polymorphisms of the RANTES gene can, therefore, be involved in the pathogenesis of coronary artery disease. We examined the association of polymorphisms in the RANTES gene with myocardial infarction in Slavonic populations of Czech and Russian origin. A total of 467 post-MI patients and 337 control subjects were genotyped for RANTES promoter G-403A (rs2107538) and intron 1.1 T/C (rs2280789) variants by PCR-SSP. Both RANTES genotypes and allele frequencies did not differ between case and control groups. Haplotype-based analysis also failed to reveal an association between MI and investigated markers. Strong linkage disequilibrium was detected between particular RANTES alleles. The data do not support an association between RANTES G-403A polymorphism and MI, as reported previously.

Laboratory of Immunogenomics and Proteomics Institute of Molecular and Translational Medicine Palacky University and Faculty Hospital Olomouc Czech Republic

Zobrazit více v PubMed

Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. British Heart Journal. 1993;69(supplement 1):S38–S41. PubMed PMC

Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–3488. PubMed

Pattison JM, Nelson PJ, Huie P, Sibley RK, Krensky AM. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. Journal of Heart and Lung Transplantation. 1996;15(12):1194–1199. PubMed

Mause SF, Von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(7):1512–1518. PubMed

Schober A, Manka D, Von Hundelshausen P, et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation. 2002;106(12):1523–1529. PubMed

Hajeer AH, Al Sharif F, Ollier WER. A polymorphism at position -403 in the human RANTES promoter. European Journal of Immunogenetics. 1999;26(5):375–376. PubMed

An P, Nelson GW, Wang L, et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(15):10002–10007. PubMed PMC

Simeoni E, Winkelmann BR, Hoffmann MM, et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. European Heart Journal. 2004;25(16):1438–1446. PubMed

Szalai C, Duba J, Prohászka Z, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis. 2001;158(1):233–239. PubMed

Böger CA, Fischereder M, Deinzer M, et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis. 2005;183(1):121–129. PubMed

McDermott DH, Beecroft MJ, Kleeberger CA, et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS. 2000;14(17):2671–2678. PubMed

Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(8):4581–4585. PubMed PMC

Kusano F, Tanaka Y, Marumo F, Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Laboratory Investigation. 2000;80(3):415–422. PubMed

Duan ZP, Zhao XY, Huang DZ, et al. RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection. Chinese Medical Journal. 2005;118(11):909–914. PubMed

Alpert JS, Antman E, Apple F, et al. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. European Heart Journal. 2000;21(18):1502–1513. PubMed

Bunce M, O’Neill CM, Barnardo MCNM, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) Tissue Antigens. 1995;46(5):355–367. PubMed

Cooke GS, Tosh K, Ramaley PA, et al. A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease. Journal of Infectious Diseases. 2006;194(5):666–669. PubMed

Hizawa N, Yamaguchi E, Konno S, Tanino Y, Jinushi E, Nishimura M. A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. American Journal of Respiratory and Critical Care Medicine. 2002;166(5):686–690. PubMed

Nickel RG, Casolaro V, Wahn U, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. Journal of Immunology. 2000;164(3):1612–1616. PubMed

Fryer AA, Spiteri MA, Bianco A, et al. The -403 G→a promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes and Immunity. 2000;1(8):509–514. PubMed

Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock

Novel insights into miRNA in lung and heart inflammatory diseases